Back to Journals » Patient Preference and Adherence » Volume 8

Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis

Authors Sobel J

Received 27 September 2013

Accepted for publication 22 November 2013

Published 16 December 2013 Volume 2014:8 Pages 31—34


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Jack D Sobel

Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USA

Abstract: Vulvovaginal candidiasis (VVC) is an extremely common cause of vaginal symptoms in women. Multiple antifungal products are available by either the oral or vaginal route, although no new drugs have become available for two decades. Given the therapeutic equivalence of the antimycotic agents and their routes of administration, the specific drug and formulation selected is entirely arbitrary in relation to final treatment outcome. Nevertheless, multiple factors affecting preference, both practitioner-dependent and patient-dependent, impact on selection of a specific drug and route of administration.

Keywords: antifungal drugs, antimycotics, Candida vaginitis, vulvovaginal candidiasis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]